Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2012 - New Market Research Report
Global Markets Direct's, 'Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Glioblastoma Multiforme (GBM), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glioblastoma Multiforme (GBM). Glioblastoma Multiforme (GBM) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release